Bioinformatics Market Scope And Analysis

  • Report Code : TIPRE00003993
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 206
Buy Now

Bioinformatics Market Analysis Report 2022 to 2028

Buy Now


Bioinformatics Market Report Scope

Report Attribute Details
Market size in 2021 US$ 12.61 Billion
Market Size by 2028 US$ 34.75 Billion
Global CAGR (2021 - 2028) 15.7%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Bioinformatics Platforms
  • Knowledge Management Tools
  • Bio Informative Services
By Application
  • Genomics
  • Proteomics
  • Chemoinformatics & Drug Design
  • Transcriptomics
  • Metabolomics
By Sector
  • Medical Biotechnology
  • Animal Biotechnology
  • Agricultural Biotechnology
  • Academics
  • Environmental Biotechnology
  • Forensic Biotechnology
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Dassault Syst mes
  • Bruker Corporation
  • Agilent Technologies Inc
  • Eurofins Scientific
  • Illumina Inc
  • PerkinElmer Inc
  • QIAGEN
  • Thermo Fisher Scientific Inc
  • Biomax Informatics AG
  • Competitive Landscape and Key Companies:

    Some of the prominent players operating in the global bioinformatics market include Agilent Technologies, Inc, Biomax Informatics Ag, Bruker Corporation, Dassault Systems, Eurofins Scientific, Geneva Bioinformatics, Illumina, PerkinElmer, Qiagen, ThermoFisher Scientific, Inc. among others. These companies focus on new technologies, advancement in the existing products and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. For instance, in March 2020, Genesis Healthcare Co., Japan's leading genetic testing and research company, launched GenesisGaia's new genomic-data-marketplace tool for R &D in Japan to empower industry researchers by increasing their productivity in crucial applications such as accelerating drug discovery, clinical development, and precision medicine, as well as strengthening the development of personalized consumer products and services.

    In January 2021, Illumina, Inc. has transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). The new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment.